Results 71 to 80 of about 126,067 (267)

Liquid chromatography–mass spectrometry method for the quantification of corticosteroids, β2-adrenoreceptor agonists and anticholinergics in human hair

open access: yes, 2020
International audiencePharmacological treatments of asthma and chronic obstructive pulmonary disease include medications such as inhaled corticosteroids, long- or short-acting β2-adrenoreceptor agonists and anticholinergics.
Salvator, Hélène   +5 more
core   +1 more source

Long‐Duration Response to Levodopa in the PPMI‐Cohort

open access: yesMovement Disorders, EarlyView.
Abstract Background Treatment of Parkinson's disease (PD) with levodopa results in a sustained reduction of symptoms. Although the plasma half‐life of levodopa is short, it elicits a lasting effect, the long‐duration levodopa response (LDR). A decrease in LDR as PD progresses has been linked to motor complications, but long‐term data on the LDR and its
Nils Schnalke   +3 more
wiley   +1 more source

Trends and Racial/Ethnic Disparities in Pharmacologic and Surgical Management of Treated Female Patients With Urinary Incontinence

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Background The current literature summarizes the trends in the surgical management of stress urinary incontinence (SUI) and not the general trends of management for all UI types in the US. Additionally, recent evidence on racial and ethnic disparities in UI related surgical utilization is limited. Objective To describe the currently prescribed
Rawan O. Almadfaa   +5 more
wiley   +1 more source

Symptom Relief and Practice Setting Variation in Bulkamid Injections for Stress Urinary Incontinence

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Introduction Bulkamid™ transurethral injection is a minimally invasive treatment for stress urinary incontinence (SUI) and mixed urinary incontinence (MUI). While effective, predictors of repeat injection, progression to sling, and the influence of anesthesia type on treatment efficacy remain incompletely defined.
Christina Sze   +6 more
wiley   +1 more source

How Can We Personalize the Delivery of Onabotulinumtoxin‐A for Patients With Neurogenic Lower Urinary Tract Dysfunction?

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Background & Aims Neurogenic lower urinary tract dysfunction (NLUTD) can produce bothersome urinary symptoms, impact quality of life, and in some cases, lead to deterioration of upper urinary tract function. Intradetrusor injection of onabotulinumtoxin‐A (BoNT‐A) is approved for NLUTD in patients who have an inadequate response to or ...
Shirley L. Wang   +2 more
wiley   +1 more source

Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2003

open access: yesCanadian Respiratory Journal, 2003
Chronic obstructive pulmonary disease (COPD) is a common cause of disability and death in Canada. Moreover, morbidity and mortality from COPD continue to rise and the economic burden is enormous.
Denis E O’donnell   +11 more
doaj   +1 more source

A multistate model to evaluate COPD progression integrating drugs consumption data and hospital databases

open access: yesEpidemiology, Biostatistics and Public Health, 2015
Background The increase in costs related to the diagnosis and treatment of chronic-degenerative diseases requires a better knowledge of the true care pathway of patients.
Nicola Bartolomeo   +2 more
doaj   +1 more source

Mirabegron and Intradetrusor Onabotulinumtoxina for Overactive Bladder in Parkinson's Disease: A Systematic Review and Meta‐Analysis

open access: yesNeurourology and Urodynamics, EarlyView.
ABSTRACT Objective To synthesize the evidence on the efficacy and safety of mirabegron and intradetrusor onabotulinumtoxinA (BoNT‐A) as separate interventions for overactive bladder (OAB) in Parkinson's disease (PD). Methods A systematic review and meta‐analysis with parallel synthesis of two distinct interventions was conducted of randomized and ...
Hussain Arshad   +4 more
wiley   +1 more source

Formoterol in the management of chronic obstructive pulmonary disease

open access: yesInternational Journal of COPD, 2008
Paschalis Steiropoulos, Argyris Tzouvelekis, Demosthenes BourosDepartment of Pneumonology, University Hospital of Alexandroupolis, GreeceAbstract: Bronchodilators represent the hallmark of symptomatic treatment of Chronic Obstructive Pulmonary Disease ...
Paschalis Steiropoulos   +2 more
doaj  

A multistate model to evaluate COPD progression integrating drugs consumption data and hospital databases

open access: yesEpidemiology, Biostatistics and Public Health, 2022
Background The increase in costs related to the diagnosis and treatment of chronic-degenerative diseases requires a better knowledge of the true care pathway of patients.
Nicola Bartolomeo, Paolo Trerotoli
doaj  

Home - About - Disclaimer - Privacy